PCSA logo

Processa Pharmaceuticals, Inc. (PCSA)

Profile

Full Name

Processa Pharmaceuticals, Inc.

Ticker

NASDAQ: PCSA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

March 7, 2014

Indexes

Not included

Website

https://www.processapharmaceuticals.com

Employees

10

Key Details

Price

$0.21(+2.99%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

-$3.87(+54.36% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.21
    PCSA price is $0.21

    30-Day Relative Volume

    0.83
    PCSA 30-day relative volume is 0.83

    Price Performance

    Price Most recent change

    +2.99%
    PCSA price was up +2.99% on Sep 17, 2025

    Price YTD change

    -76.58%
    PCSA price is down -76.58% since January 1st

    Price 1-year change

    -85.42%
    PCSA price is down -85.42% year-on-year

    Price 3-year change

    -99.55%
    PCSA price is down -99.55% over the past 3 years

    Price Range

    Price All-time high

    $2695.00
    PCSA price is currently -99.99% below its historical high of $2695.00

    Price 3-year low

    $0.15
    PCSA price is currently +38.00% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $10.42M
    PCSA market capitalization is $10.42 million

    Market cap 3-year change

    -71.17%
    PCSA market capitalization is down -71.17% over the past 3 years

    Market cap All-time high

    $203.96M
    PCSA market capitalization is currently -94.89% below its historical high of $203.96 million

    Market cap sector rank

    15.77%
    PCSA market capitalization is higher than 15.77% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +1445.92%
    PCSA shares outstanding is up +1445.92% year-on-year

    Shares Outstanding 3-Year Change

    +6250.79%
    PCSA shares outstanding is up +6250.79% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.46
    PCSA beta is 0.46

    200-day SMA

    $0.44
    PCSA price is currently -53.01% below its 200-day simple moving average

    50-day SMA

    $0.21
    PCSA price is currently -3.36% below its 50-day simple moving average

    RSI

    52.94
    PCSA 14-day relative strength index is 52.94

    Volume

    0.83
    PCSA 30-day relative volume is 0.83

    ATR

    $0.02
    PCSA average true range is $0.02

    10-day Historical Volatility

    76.22%
    PCSA 10-day historical volatility is 76.22%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    PCSA annual revenue is $0.00

    Revenue Analysts estimate

    -
    PCSA annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    0%
    PCSA annual revenue has remained unchanged year-on-year

    Revenue Sector rank

    28.79%
    PCSA annual revenue is higher than 28.79% of companies in Healthcare sector

    EPS

    EPS

    -$3.87
    PCSA annual earnings per share is -$3.87

    EPS Analysts estimate

    -$0.43
    PCSA annual earnings per share is currently +800.00% higher than the consensus analysts' forecast

    EPS 1-year change

    +54.36%
    PCSA annual earnings per share is up +54.36% year-on-year

    EPS Sector rank

    23.34%
    PCSA annual earnings per share is higher than 23.34% of companies in Healthcare sector

    Profit

    Gross profit

    -$800.00
    PCSA annual gross profit is -$800.00

    Gross margin

    -
    PCSA annual gross profit margin value is unknown

    Operating profit

    -$12.05M
    PCSA annual operating income is -$12.05 million

    Operating margin

    -
    PCSA annual operating profit margin value is unknown

    Net income

    -$11.85M
    PCSA annual net profit is -$11.85 million

    Net margin

    -
    PCSA annual net profit margin value is unknown

    Expenses

    Total expenses

    $11.85M
    PCSA annual total expenses is $11.85 million

    Operating expenses

    $12.05M
    PCSA annual total operating expenses is $12.05 million

    Cost of goods sold

    $800.00
    PCSA annual cost of goods sold is $800.00

    Selling, general & administrative expenses

    $0.00
    PCSA annual SGA is $0.00

    Depreciation and amortization

    $800.00
    PCSA annual depreciation & amortization is $800.00

    Interest expense

    $0.00
    PCSA annual interest expense is $0.00

    Income tax

    $0.00
    PCSA annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$12.05M
    PCSA annual earnings before interest & taxes is -$12.05 million

    EBITDA

    -$12.05M
    PCSA annual EBITDA is -$12.05 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $3.23M
    PCSA annual total assets is $3.23 million

    Non current assets

    $1.36M
    PCSA annual long term assets is $1.36 million

    Current assets

    $1.87M
    PCSA annual total current assets is $1.87 million

    Cash and cash equivalents

    $1.19M
    PCSA annual cash & cash equivalents is $1.19 million

    Accounts receivable

    -
    PCSA annual accounts receivable value is unknown

    Inventory

    $0.00
    PCSA annual inventory is $0.00

    Liabilities

    Total liabilities

    $1.53M
    PCSA annual total liabilities is $1.53 million

    Long term liabilities

    $500.00
    PCSA annual total long term liabilities is $500.00

    Current liabilities

    $1.53M
    PCSA annual total current liabilities is $1.53 million

    Accounts payable

    $880.90K
    PCSA annual accounts payable is $880.90 thousand

    Debt

    Total debt

    $73.50K
    PCSA annual total debt is $73.50 thousand

    Total debt 1-year change

    -51.2%
    PCSA annual total debt is down -51.2% year-on-year

    Long term debt

    $500.00
    PCSA annual long term debt is $500.00

    Short term debt

    $73.00K
    PCSA annual short term debt is $73.00 thousand

    Equity & Capital

    Shareholders equity

    $1.70M
    PCSA annual stockholders equity is $1.70 million

    Book value

    $1.70M
    PCSA annual book value is $1.70 million

    Retained earnings

    -$87.22M
    PCSA annual retained earnings is -$87.22 million

    Working capital

    $341.00K
    PCSA annual working capital is $341.00 thousand

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$11.24M
    PCSA annual cash flow from operations is -$11.24 million

    Cash from operations 1-year change

    -39.46%
    PCSA annual cash flow from operations is down -39.46% year-on-year

    Cash from investing

    -$3200.00
    PCSA annual cash flow from investing activities is -$3200.00

    Cash from investing 1-year change

    -14.29%
    PCSA annual cash flow from investing activities is down -14.29% year-on-year

    Cash from financing

    $7.73M
    PCSA annual cash flow from financing activities is $7.73 million

    Cash from financing 1-year change

    +23.37%
    PCSA annual cash flow from financing activities is up +23.37% year-on-year

    CAPEX

    CAPEX

    $3200.00
    PCSA annual capital expenditures is $3200.00

    CAPEX 1-year change

    +14.29%
    PCSA annual capital expenditures is up +14.29% year-on-year

    Free Cash Flow

    Free cash flow

    -$11.25M
    PCSA annual free cash flow is -$11.25 million

    Free cash flow 1-year change

    -39.45%
    PCSA annual free cash flow is down -39.45% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    PCSA annual gross profit margin value is unknown

    Operating margin

    -
    PCSA annual operating profit margin value is unknown

    Net margin

    -
    PCSA annual net profit margin value is unknown

    ROA & ROE

    ROA

    -262.87%
    PCSA annual return on assets is -262.87%

    ROE

    -354.51%
    PCSA annual return on equity is -354.51%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    PCSA price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    PCSA price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.71
    PCSA price to book ratio is 1.71

    PB ratio Sector rank

    49.71%
    PCSA price to book ratio is higher than 49.71% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    PCSA price to sales ratio value is unknown

    PS ratio Sector rank

    -
    PCSA price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $3.51M
    PCSA enterprise value is $3.51 million

    Enterprise value Sector rank

    16.07%
    PCSA enterprise value is higher than 16.07% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.27
    PCSA EV/EBITDA is -0.27

    EV/EBITDA Sector rank

    58.65%
    PCSA EV/EBITDA is higher than 58.65% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.22
    PCSA annual current ratio is 1.22

    Quick ratio

    1.22
    PCSA annual quick ratio is 1.22

    Leverage

    Debt to equity

    0.04
    PCSA annual debt to equity ratio is 0.04

    Interest coverage ratio

    -
    PCSA annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    PCSA piotroski f-score value is unknown

    Altman Z-Score

    -45.92
    PCSA altman z-score is -45.92

    Analyst ratings

    Recent major analysts updates

    Sep 2, 25 HC Wainwright & Co.
    Buy
    Jun 30, 25 HC Wainwright & Co.
    Buy
    Dec 5, 24 HC Wainwright & Co.
    Buy
    Aug 20, 24 HC Wainwright & Co.
    Buy
    Aug 19, 24 HC Wainwright & Co.
    Buy
    Aug 1, 24 HC Wainwright & Co.
    Buy
    Jun 12, 24 HC Wainwright & Co.
    Buy
    May 13, 24 HC Wainwright & Co.
    Buy
    Apr 25, 24 HC Wainwright & Co.
    Buy
    Mar 6, 24 Benchmark
    Speculative Buy

    Institutional Ownership

    Screeners with PCSA included

    Growing Shares Outstanding
    Stocks cheaper than 1 dollar
    US stocks
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Processa Pharmaceuticals, Inc.?
    • Does Processa Pharmaceuticals, Inc. pay dividends?
    • What sector is Processa Pharmaceuticals, Inc. in?
    • What industry is Processa Pharmaceuticals, Inc. in?
    • What country is Processa Pharmaceuticals, Inc. based in?
    • When did Processa Pharmaceuticals, Inc. go public?
    • Is Processa Pharmaceuticals, Inc. in the S&P 500?
    • Is Processa Pharmaceuticals, Inc. in the NASDAQ 100?
    • Is Processa Pharmaceuticals, Inc. in the Dow Jones?
    • When was Processa Pharmaceuticals, Inc.'s last earnings report?
    • When does Processa Pharmaceuticals, Inc. report earnings?

    What is the ticker symbol for Processa Pharmaceuticals, Inc.?

    The ticker symbol for Processa Pharmaceuticals, Inc. is NASDAQ:PCSA

    Does Processa Pharmaceuticals, Inc. pay dividends?

    No, Processa Pharmaceuticals, Inc. does not pay dividends

    What sector is Processa Pharmaceuticals, Inc. in?

    Processa Pharmaceuticals, Inc. is in the Healthcare sector

    What industry is Processa Pharmaceuticals, Inc. in?

    Processa Pharmaceuticals, Inc. is in the Biotechnology industry

    What country is Processa Pharmaceuticals, Inc. based in?

    Processa Pharmaceuticals, Inc. is headquartered in United States

    When did Processa Pharmaceuticals, Inc. go public?

    Processa Pharmaceuticals, Inc.'s initial public offering (IPO) was on March 7, 2014

    Is Processa Pharmaceuticals, Inc. in the S&P 500?

    No, Processa Pharmaceuticals, Inc. is not included in the S&P 500 index

    Is Processa Pharmaceuticals, Inc. in the NASDAQ 100?

    No, Processa Pharmaceuticals, Inc. is not included in the NASDAQ 100 index

    Is Processa Pharmaceuticals, Inc. in the Dow Jones?

    No, Processa Pharmaceuticals, Inc. is not included in the Dow Jones index

    When was Processa Pharmaceuticals, Inc.'s last earnings report?

    Processa Pharmaceuticals, Inc.'s most recent earnings report was on November 13, 2024

    When does Processa Pharmaceuticals, Inc. report earnings?

    The date for Processa Pharmaceuticals, Inc.'s next earnings report has not been announced yet
    On this page